|
|||||
|
Latest Insider Trading | Top Insider Trading Recent Week | Top 10% Owner Trading Recent Week | Filter |
Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Jun 04 | Sale | 89.60 | 2,435 | 218,176 | 98,550 | Jun 04 09:12 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Apr 01 | Option Exercise | 1.16 | 20,000 | 23,250 | 121,819 | Apr 06 08:00 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Apr 05 | Option Exercise | 1.16 | 20,000 | 23,250 | 121,819 | Apr 06 08:00 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Apr 06 | Option Exercise | 1.16 | 10,000 | 11,625 | 111,819 | Apr 06 08:00 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Apr 06 | Sale | 111.68 | 10,000 | 1,116,800 | 101,819 | Apr 06 08:00 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Apr 05 | Sale | 113.06 | 20,000 | 2,261,200 | 101,819 | Apr 06 08:00 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Apr 01 | Sale | 114.40 | 20,000 | 2,288,000 | 101,819 | Apr 06 08:00 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Mar 01 | Option Exercise | 1.16 | 20,000 | 23,250 | 125,087 | Mar 03 09:55 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Mar 02 | Option Exercise | 1.16 | 20,000 | 23,250 | 125,087 | Mar 03 09:55 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Mar 03 | Option Exercise | 1.16 | 20,000 | 23,250 | 123,771 | Mar 03 09:55 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Mar 03 | Sale | 112.98 | 21,952 | 2,480,244 | 101,819 | Mar 03 09:55 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Mar 02 | Sale | 117.32 | 20,000 | 2,346,400 | 105,087 | Mar 03 09:55 PM |
ALLK | RASMUSSEN HENRIK S MD | Chief Medical Officer | Mar 01 | Sale | 120.66 | 20,000 | 2,413,200 | 105,087 | Mar 03 09:55 PM |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite